GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:005160412 | Liver | HCC | protein maturation | 171/7958 | 294/18723 | 3.80e-08 | 8.30e-07 | 171 |
GO:001648511 | Liver | HCC | protein processing | 121/7958 | 225/18723 | 4.01e-04 | 2.71e-03 | 121 |
GO:00063021 | Liver | HCC | double-strand break repair | 131/7958 | 251/18723 | 1.17e-03 | 6.54e-03 | 131 |
GO:0070071 | Liver | HCC | proton-transporting two-sector ATPase complex assembly | 12/7958 | 15/18723 | 3.56e-03 | 1.59e-02 | 12 |
GO:005160420 | Thyroid | PTC | protein maturation | 132/5968 | 294/18723 | 1.71e-06 | 2.39e-05 | 132 |
GO:00164859 | Thyroid | PTC | protein processing | 95/5968 | 225/18723 | 6.60e-04 | 4.15e-03 | 95 |
GO:00349822 | Thyroid | PTC | mitochondrial protein processing | 10/5968 | 13/18723 | 1.11e-03 | 6.51e-03 | 10 |
GO:00700712 | Thyroid | PTC | proton-transporting two-sector ATPase complex assembly | 11/5968 | 15/18723 | 1.19e-03 | 6.84e-03 | 11 |
GO:00063026 | Thyroid | PTC | double-strand break repair | 103/5968 | 251/18723 | 1.30e-03 | 7.40e-03 | 103 |
GO:00063032 | Thyroid | PTC | double-strand break repair via nonhomologous end joining | 32/5968 | 66/18723 | 3.55e-03 | 1.71e-02 | 32 |
GO:0051604110 | Thyroid | ATC | protein maturation | 136/6293 | 294/18723 | 4.00e-06 | 4.42e-05 | 136 |
GO:001648515 | Thyroid | ATC | protein processing | 100/6293 | 225/18723 | 4.39e-04 | 2.62e-03 | 100 |
GO:000630212 | Thyroid | ATC | double-strand break repair | 110/6293 | 251/18723 | 4.48e-04 | 2.65e-03 | 110 |
GO:00349821 | Thyroid | ATC | mitochondrial protein processing | 10/6293 | 13/18723 | 1.77e-03 | 8.71e-03 | 10 |
GO:007007111 | Thyroid | ATC | proton-transporting two-sector ATPase complex assembly | 11/6293 | 15/18723 | 1.94e-03 | 9.41e-03 | 11 |
GO:00063031 | Thyroid | ATC | double-strand break repair via nonhomologous end joining | 33/6293 | 66/18723 | 4.27e-03 | 1.80e-02 | 33 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ATP23 | SNV | Missense_Mutation | | c.292N>T | p.Gly98Cys | p.G98C | Q9Y6H3 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-A8-A09A-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD |
ATP23 | insertion | In_Frame_Ins | novel | c.483_484insGTGCTGTTGTGTTTTGCACTTCTTTCTGAAGGTCTT | p.Cys161_Ser162insValLeuLeuCysPheAlaLeuLeuSerGluGlyLeu | p.C161_S162insVLLCFALLSEGL | Q9Y6H3 | protein_coding | | | TCGA-A2-A0CU-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | tamoxiphen | SD |
ATP23 | insertion | Nonsense_Mutation | novel | c.11_12insGAGGCTGGAAAGAGTTTTAGGCCAAATCAGGAATAGCTGAAAGCCAGT | p.Ala4_Pro5insArgLeuGluArgValLeuGlyGlnIleArgAsnSerTerLysProVal | p.A4_P5insRLERVLGQIRNS*KPV | Q9Y6H3 | protein_coding | | | TCGA-A7-A6VV-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cyclophosphamide | CR |
ATP23 | deletion | Frame_Shift_Del | novel | c.207delN | p.Asp71MetfsTer3 | p.D71Mfs*3 | Q9Y6H3 | protein_coding | | | TCGA-AN-A0XS-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
ATP23 | deletion | Frame_Shift_Del | novel | c.209delN | p.Asp71MetfsTer3 | p.D71Mfs*3 | Q9Y6H3 | protein_coding | | | TCGA-AN-A0XS-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
ATP23 | insertion | Nonsense_Mutation | novel | c.418_419insAACTTCTCCCTTCTCCTCTCTCT | p.Trp140Ter | p.W140* | Q9Y6H3 | protein_coding | | | TCGA-AR-A0U0-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ATP23 | SNV | Missense_Mutation | novel | c.235N>A | p.Ala79Thr | p.A79T | Q9Y6H3 | protein_coding | tolerated(0.57) | benign(0.012) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
ATP23 | SNV | Missense_Mutation | | c.478N>T | p.Asp160Tyr | p.D160Y | Q9Y6H3 | protein_coding | deleterious(0) | probably_damaging(0.976) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR |
ATP23 | SNV | Missense_Mutation | novel | c.241A>G | p.Asn81Asp | p.N81D | Q9Y6H3 | protein_coding | tolerated(0.97) | benign(0.001) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
ATP23 | SNV | Missense_Mutation | | c.703N>A | p.Asp235Asn | p.D235N | Q9Y6H3 | protein_coding | deleterious(0.04) | benign(0.006) | TCGA-AP-A059-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |